Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. - Wikidata - awgldk - TriplyDB

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

http://www.wikidata.org/entity/Q34718476

about

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population Perspectives on systems biology applications in diabetic kidney disease Challenges in elucidating the genetics of diabetic retinopathy Diabetes-induced oxidative DNA damage alters p53-p21CIP1/Waf1 signaling in the rat testis NRF2 plays a protective role in diabetic retinopathy in mice Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population.Fracture risk in diabetic elderly men: the MrOS study.Juvenile Diabetes Research Foundation: mission, strategy, and priorities Time-dependent alterations in rat macrovessels with type 1 diabetes Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.Vascular complications of diabetes: mechanisms of injury and protective factors PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.Implications of treatment that target protective mechanisms against diabetic nephropathy Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.Clinical profile of long-term survivors and nonsurvivors with type 2 diabetes.Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes.Cardiovascular risk in type 1 diabetes mellitus.Diabetic Retinopathy: Battling the Global Epidemic.The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes.Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy.Coming full circle in diabetes mellitus: from complications to initiation.Painful and painless diabetic neuropathy: one disease or two?Effect of diet-derived advanced glycation end products on inflammation.Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.C-peptide antioxidant adaptive pathways in β cells and diabetes.Targeting insulin-producing beta cells for regenerative therapy.Bone health in subjects with type 1 diabetes for more than 50 years.Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.

P2860

Q24200376-612010C9-0D42-49CC-B90D-A1C1E2CDABD0 Q26777077-8F086875-ED68-4517-8A65-4714640252B4 Q26823206-F0B9F603-668D-4CE6-A281-6C5ACD530174 Q26998699-2A8EC7DF-3CC2-417E-83A9-80F8A2EDB7C5 Q28567929-62B0E6E3-A70F-4975-89E1-D443E9565DE9 Q30579323-CDCB2BC4-C497-4396-A639-E1DD7162285D Q33583006-B8281170-D3B2-40D1-990D-C13F55377184 Q33960253-F145E03E-4CC5-4F4E-A7F2-F19C94800374 Q34256592-A0C222B3-FA82-4751-BDE7-5B93996876CC Q35104388-7A9ECF41-08A5-4D16-8B71-06D6D0AE3290 Q35130554-C5CEF028-ED66-466F-9D91-44CAB85D218A Q35612407-8F005E78-FFB0-4E25-A097-3D18832BB731 Q35726140-A7A95067-A18C-45B8-A9B7-E2AA6BCF0A9E Q35803421-073D908B-903D-4F50-A9D1-240D556478A7 Q35896615-DC99081D-EB2D-43B2-8BD1-C0F74126D4D9 Q35995060-C42AF0D0-6B6B-4667-A1CD-D6664005C9D7 Q36030387-0CC5456D-5E62-42A7-BA70-65B8EB04B3D1 Q36128952-EF7F600B-33F3-4517-B766-E424BBC2E06F Q36503503-5C6D00AD-9268-4FE7-AA04-121341BF9573 Q36537262-BD80A5EB-6FC8-4B2C-906B-25A4ED88166E Q36618518-299E7EA9-8D91-44C7-904D-2EE80EB06BCD Q36645971-2FAC8D49-A8E2-43DF-AEB7-B53D4F80E179 Q36796216-1EC5EF1E-67A7-40CD-9006-08AFD3C3B166 Q37022541-F68BC86C-532E-46F8-B14A-9F0DC5233515 Q37193424-888E3933-2EC2-46DB-81E2-DFF8E5A0475B Q37314740-22F82906-2021-4B21-8B92-0450984750C1 Q37494858-2E26573E-1CEF-47BA-9529-93C774202378 Q37660885-96EA1B3F-3F5C-480A-A7B1-27AD12C70F87 Q37694160-1F4A8A4A-A851-4806-9B79-FD74BFF2C894 Q37969921-F53A049B-0EC2-4AC9-9DF3-614F696F2A47 Q38072272-2FF79C92-60D7-4E7A-9A4C-62A62ECDBDDB Q38107138-2D3C59EE-A809-4CAB-A461-FF1B3EFA4738 Q38588208-86585B13-FD4D-4BD6-93FD-6FDECE908683 Q38706335-B2CF523C-0976-4C2B-BA67-D0B68EFF5D97 Q38805725-46F4549E-4AB9-4F3F-8403-3DCEF19ED1AD Q38848764-127108A8-F3BD-4CA0-BCE1-EB7D684CA48F Q38850708-7622B42D-64C1-4505-8B66-E6788FD180A7 Q38895694-389046BF-07C1-4CBA-8A44-451D29CD5A39 Q38943012-D64FA5CF-AE19-414C-9708-C0E3455B7188 Q39409210-AD8273F3-5FC9-42C6-83BA-AD1FE8F5D059

P2860

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

http://www.wikidata.org/entity/Q34718476

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Protection from retinopathy an ...... joslin 50-year medalist study.

@ast

Protection from retinopathy an ...... joslin 50-year medalist study.

@en

Protection from retinopathy an ...... joslin 50-year medalist study.

@nl

type

label

Protection from retinopathy an ...... joslin 50-year medalist study.

@ast

Protection from retinopathy an ...... joslin 50-year medalist study.

@en

Protection from retinopathy an ...... joslin 50-year medalist study.

@nl

prefLabel

Protection from retinopathy an ...... joslin 50-year medalist study.

@ast

Protection from retinopathy an ...... joslin 50-year medalist study.

@en

Protection from retinopathy an ...... joslin 50-year medalist study.

@nl

P1433

Q34718476-2CAE6027-FB3E-46BD-9DF6-F79C922F7B02

P1476

Q34718476-AF413B27-CB0E-4E8C-ACFD-8FBC13A639BC

P2093

Q34718476-26B60D37-2E90-41C4-B6B9-D001F48B7EA1

Q34718476-4692D6A9-C4F4-417E-BE5E-F72360B7027C

Q34718476-76F5919B-085E-413D-8235-426AF11FBFF3

Q34718476-86133661-56FD-4A24-B62E-EAD2B70279CF

Q34718476-86632C3E-68D9-4451-B52F-6DAA9C4375F1

Q34718476-928B78A5-E556-4DC4-A5D7-5008D50BF7D4

Q34718476-A224A96E-F751-4B15-AF83-633717B2A319

Q34718476-DB7BE560-67F8-4C81-B65B-052DF5E7C0FC

Q34718476-E78A65CA-8A94-48A8-9D40-DF327FA4C07F

Q34718476-E79227A1-A7ED-451C-9867-557365ABBCE6

P2860

Q34718476-028085FB-495C-4572-A958-8CE044A8E65D

Q34718476-1743A577-17E9-4A50-98BF-48F2DA96D6B8

Q34718476-185B7FD0-A690-45A4-A80A-4EF0DFCF8B0A

Q34718476-348A743B-4C40-48C3-AB72-0A7D2CFD38A1

Q34718476-3DDD6E90-C9EF-48D8-8B6D-E9A0122AAB1F

Q34718476-3E122D30-7988-479E-8743-51434668F80A

Q34718476-545A71DC-4630-43DE-A0E9-48B47494647C

Q34718476-60918259-60ED-44BE-8BE3-FED35128C0D1

Q34718476-8163F8FF-6647-4BE1-A58A-E47CC07E765C

Q34718476-A73CA601-2D42-4402-A817-9528B7B0C5EC

P304

Q34718476-5720962C-CCBE-40A2-85CB-0D5A997E7207

P31

Q34718476-064B7E74-99AA-477A-8238-19ADEBE703D7

P356

Q34718476-03EFCFC6-1C09-4387-8524-26FB7C0375F9

P407

Q34718476-00A49684-AB16-41D2-96CD-4FCA4972639E

P433

Q34718476-A508E56C-F1D3-4CA9-95A8-7E4B2425076B

P478

Q34718476-91BA91A9-DC45-4B05-AD55-4412E66BBFB8

P50

Q34718476-D53DA6A8-70EA-42F0-8F6F-D933CE61548C

P577

Q34718476-2379882A-80BE-4439-B3BF-B0D83A42A7F1

P5875

Q34718476-26F78198-9573-419B-9F7E-632D6B8971F3

P698

Q34718476-B59793ED-3E1A-4698-91AC-BB7CBE882E25

P921

Q34718476-2567B867-C33A-4B36-A604-7C65F7AAD39F

Q34718476-96A3C964-06A2-4F18-97BC-6B20FAF23148

P932

Q34718476-BD14B93E-6CF5-4AAC-BE1B-9848F7D683F9

P356

P1433

P1476

Protection from retinopathy an ...... joslin 50-year medalist study

@en

P2093

Bela F Asztalos

http://www.w3.org/2001/XMLSchema#string

Christopher M Strauch

http://www.w3.org/2001/XMLSchema#string

David R Sell

http://www.w3.org/2001/XMLSchema#string

Ernst J Schaefer

http://www.w3.org/2001/XMLSchema#string

George L King

http://www.w3.org/2001/XMLSchema#string

Hillary A Keenan

http://www.w3.org/2001/XMLSchema#string

Jennifer K Sun

http://www.w3.org/2001/XMLSchema#string

Jerry D Cavallerano

http://www.w3.org/2001/XMLSchema#string

Lloyd Paul Aiello

http://www.w3.org/2001/XMLSchema#string

Vincent M Monnier

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Global estimates of the prevalence of diabetes for 2010 and 2030

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Vitamin C-mediated Maillard reaction in the lens probed in a transgenic-mouse model.

Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study.

Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort).

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress.

Diabetes and advanced glycation endproducts.

Advanced glycation endproducts: what is their relevance to diabetic complications?

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.

P304

968-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-1675

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Doria

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50907245

http://www.w3.org/2001/XMLSchema#string

P698

21447665

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3064059

http://www.w3.org/2001/XMLSchema#string